OncoAnalyserDx RUO
For Australia and Research Use Only
Hartwig Medical Foundation has developed software tools to analyse Next Generation Sequencing (NGS) data to detect genomic events in tumors. After extensive validations and landmark publications, these open-source tools called WiGiTS have proven to deliver comprehensive molecular analyses. Collaborators at the University of Melbourne, assembled WiGiTS into a single pipeline called oncoanalyser and made it freely available to the community via nf-core.
Oncoanalyser is now being incorporated into a software as a service (SaaS) cloud-based platform called OncoAnalyserDx. OncoAnalyserDx is in development with early access testing partners and is currently Research Use Only.
OncoAnalyserDx RUO consists of:
- a portal to upload data (FASTQ/BAM), manage samples and download analysis results
- oncoanalyser software for secondary analysis of panel or WGS data
- a soft touch tertiary analysis platform for variant curation and customised reporting
Want to Know More?
For more information on OncoAnalyserDx please contact Nicole Schonrock at n.schonrock@hartwigmedicalfoundation.nl
A complete genetic analysis should be part of the standard diagnostics for every patient with cancer who is eligible for treatment. WGS contributes to better, coordinated treatment advice. In this way, we reduce over- and under-treatment, while making healthcare more cost-effective and keeping it affordable.